A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes.
about
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic SuccessesGut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutideSingle-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes.Effects of dietary polyphenols on neuroregulatory factors and pathways that mediate food intake and energy regulation in obesity.Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes.Liraglutide counteracts obesity and glucose intolerance in a mouse model of glucocorticoid-induced metabolic syndrome.Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation.
P2860
Q28067465-54FD40F7-AD06-41E3-8F36-B1E91961B542Q28081671-0D09FBF2-548F-45D5-98F6-819C3A435824Q37348520-ED1486CB-73D8-4D21-8513-23B4604820FCQ38057717-DAF1221B-D5E9-4D4D-AA1D-EABEB49026EAQ38662690-80535C4D-0176-47C0-87ED-19A1281755EAQ41822981-8FF74A0A-E240-43DD-B0FA-9487D02C3C29Q51009649-164671E2-A160-479B-8A9D-BF1911DDB15B
P2860
A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A comparison of currently avai ...... treatment of type 2 diabetes.
@en
type
label
A comparison of currently avai ...... treatment of type 2 diabetes.
@en
prefLabel
A comparison of currently avai ...... treatment of type 2 diabetes.
@en
P2860
P1476
A comparison of currently avai ...... treatment of type 2 diabetes.
@en
P2860
P304
P356
10.1517/14656566.2012.692777
P407
P577
2012-07-01T00:00:00Z